Lumida
/PRME
⌘K
Prime Medicine Inc

Prime Medicine Inc

PRME
$3.13USD-6.57%-0.22 today

MARKET CAP

567.7M

P/E (TTM)

FWD P/E

DAY RANGE

$3 – $3

52W RANGE

$3
$7

AI Summary

Stalk
Buy NowMedium

PRME is in an Early Stage 1 consolidation range after a prolonged downtrend, with the 9 and 21 EMAs having repaired and turned slightly upward. The Bullish Pivot Point pattern signals failed downside control and structural repair, giving a bullish medium-term mean-reversion bias against a bearish secular trend. Execution favors a Buy Now stance on a pullback into the rising EMA support zone within the base.

  • Q2 revenue beat by 4.4% and EPS beat by 6.3%
  • Net loss narrowed 20% YoY to $42.1M
  • Earnings yield is negative and profitability remains weak
Full analysis →

Buying

8

institutions

Selling

7

institutions

New Positions

4

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

InstitutionActionShares HeldValueChangeChg %Weight
BI

Blackrock, Inc.

Q2 2026

BUY9.60 M35.43 M+1.10 M+19.8%0.00%
TR

T. Rowe Price Investment Management, Inc.

Q2 2026

SELL5.24 M19.33 M+-244.56 K+1.3%0.01%
BA

Balyasny Asset Management L.P.

Q2 2026

SELL3.97 M14.65 M+-154.28 K+2.1%0.02%
WP

Woodline Partners LP

Q2 2026

SELL3.00 M11.08 M+-3.00 M-47.0%0.03%
CA

Citadel Advisors LLC

Q2 2026

BUY2.35 M8.68 M+1.76 M+317.3%0.00%
AC

Adar1 Capital Management, LLC

Q2 2026

BUY2.00 M7.37 M+24.27 K+7.3%0.34%
FC

Farallon Capital Management, L.l.c.

Q2 2026

BUYNEW1.24 M4.58 M+1.24 M+0.0%0.02%
JC

Jpmorgan Chase & Co

Q2 2026

SELL810.10 K3.01 M+-34.06 K+13.3%0.00%
PA

Point72 Asset Management, L.P.

Q2 2026

BUYNEW533.55 K1.97 M+533.55 K+0.0%0.00%
MM

Millennium Management LLC

Q2 2026

BUYNEW427.10 K1.58 M+427.10 K+0.0%0.00%
AC

Aqr Capital Management LLC

Q2 2026

SELL118.00 K435.41 K+-436.94 K-77.5%0.00%
RT

Renaissance Technologies LLC

Q2 2026

SELL117.41 K433.25 K+-623.63 K-83.2%0.00%
JH

Janus Henderson Group Plc

Q1 2026

BUY121.80 K423.26 K+60.90 K+101.2%0.00%
RC

Rockefeller Capital Management L.P.

Q2 2026

SELL90.73 K334.81 K+-666.00+5.3%0.00%
BH

Brevan Howard Capital Management LP

Q2 2026

BUYNEW12.91 K47.64 K+12.91 K+0.0%0.00%